0.30
3.54%
-0.011
Aclarion Inc stock is currently priced at $0.30, with a 24-hour trading volume of 138.20K.
It has seen a -3.54% decreased in the last 24 hours and a -0.03% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $0.3103 pivot point. If it approaches the $0.2969 support level, significant changes may occur.
Previous Close:
$0.311
Open:
$0.3056
24h Volume:
138.20K
Market Cap:
$2.46M
Revenue:
$75,400
Net Income/Loss:
$-4.91M
P/E Ratio:
-0.5357
EPS:
-0.56
Net Cash Flow:
$-3.77M
1W Performance:
-4.00%
1M Performance:
-0.03%
6M Performance:
+11.11%
1Y Performance:
-69.57%
Aclarion Inc Stock (ACON) Company Profile
Name
Aclarion Inc
Sector
Industry
Phone
650-241-1741
Address
951 Mariners Island Boulevard, Suite 300, San Mateo
Aclarion Inc Stock (ACON) Latest News
A significant driver of top-line growth: Aclarion Inc (ACON) – Sete News - SETE News
SETE News
Aclarion, Inc. (NASDAQ:ACON) Short Interest Update - Defense World
Defense World
Financial Snapshot: Analyzing Aclarion Inc (ACON)'s Key Ratio Metrics – DWinneX - The Dwinnex
The Dwinnex
Aclarion Inc (ACON) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle
The InvestChronicle
Aclarion Inc (ACON) stock analysis: A simple moving average approach – US Post News - US Post News
US Post News
Riding the Waves: A Guide to Investing in ACON Stock - The InvestChronicle
The InvestChronicle
Aclarion Inc Stock (ACON) Financials Data
Aclarion Inc (ACON) Revenue 2024
ACON reported a revenue (TTM) of $75.40 thousand for the quarter ending December 31, 2023, a +24.83% rise year-over-year.
Aclarion Inc (ACON) Net Income 2024
ACON net income (TTM) was -$4.91 million for the quarter ending December 31, 2023, a +30.52% increase year-over-year.
Aclarion Inc (ACON) Cash Flow 2024
ACON recorded a free cash flow (TTM) of -$3.77 million for the quarter ending December 31, 2023, a +26.98% increase year-over-year.
Aclarion Inc (ACON) Earnings per Share 2024
ACON earnings per share (TTM) was -$8.98 for the quarter ending December 31, 2023, a +38.27% growth year-over-year.
About Aclarion Inc
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
Cap:
|
Volume (24h):